profit slide india dr reddy profit indian drugmaker dr reddys fell 93 research cost rise sale flag firm say profit 40m rupee 915000 486000 three month december sale fell 8 47bn rupee dr reddys built reputation produce generic version bigname pharmaceutical product competition intensified firm company short new product launch recent annoucement december 2000 won exclusive marketing right generic version famous antidepressant prozac maker eli lilly also lose key court case march 2004 ban sell version pfizers popular hypertension drug norvasc us research development new drug continue apace rd spending rise 37 705m rupee key cause decrease profit alongside fall sale patent number wellknown product due run near future represent opportunity dr reddy whose share list new york indian generic manufacturer sale dr reddys generic business fell 86 966m rupee another staple firm business sale ingredient drug also perform poorly sale 25 previous year 14bn rupee face strong competition home us europe dr reddys indian competitor gathering strength although face heavy competitive pressure 